SCHEMBL6981978

SCHEMBL6981978

Cc1cccc2c1O[C@@H](CO)CO2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MTNR1A P48039 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
MAP3K14 Q99558 1/20 0.39
ADRA1A P35348 5/20 0.39
ADRA1D P25100 4/20 0.39
ADRA1B P35368 4/20 0.39
HTT P42858 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
DRD1 P21728 1/20 0.39
TBXA2R P21731 1/20 0.39
SLC6A2 P23975 1/20 0.39
DRD3 P35462 1/20 0.39
RAB9A P51151 1/20 0.38
POLB P06746 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981984 1.00 CA2 (0.41) CA2ALDH1A1MTNR1AKDM4EHPGD
SCHEMBL11006242 0.87 CA2 (0.42) CA2MTNR1AMAP3K14ADRA1AADRA1D
SCHEMBL1021052 0.83 ADRA1A (0.47) CA2HPGDADRA1AADRA1DADRA1B
SCHEMBL6985807 0.83 ADRA1A (0.49) CA2ALDH1A1MTNR1AADRA1AADRA1D
SCHEMBL11097027 0.83 CA2 (0.44) CA2ALDH1A1MTNR1AADRA1AADRA1D
SCHEMBL11475106 0.83 CA2 (0.44) CA2MTNR1AADRA1AADRA1DADRA1B
SCHEMBL6985813 0.83 ADRA1A (0.49) CA2ALDH1A1MTNR1AADRA1AADRA1D
SCHEMBL6974656 0.83 ADRA1A (0.47) CA2HPGDADRA1AADRA1DADRA1B
SCHEMBL4961826 0.82 CA2 (0.40) CA2ALDH1A1MTNR1AKDM4EHPGD
SCHEMBL6982180 0.82 CA2 (0.59) CA2ADRA1AADRA1DADRA1BHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed
EP-0841334-B1 PROCESS FOR PRODUCING 1,4-BENZODIOXANE DERIVATIVES DAISO CO LTD (JP) 2001-10-04 EP disclosed
US-5935973-A AFFINITY FOR 5-HT1A, ALPHA1, ALPHA2 AND/OR D2 RECEPTORS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS, PSYCHOSES, DYSKINESIAS, PARKINSON'S DISEASE, HYPOTENSIVE AGENTS, TOURETTE'S SYNDROME, OBSESSIVE-COMPULSIVE BEHAVIOUR, PANIC ATTACKS, SOCIAL PHOBIAS KNOLL AKTIENGESELLSCHAFT (DE) 1999-08-10 US disclosed
US-5780650-A Process for preparation of 1,4-benzodioxane derivative DAISO CO., LTD. (JP) 1998-07-14 US disclosed
EP-0841334-A1 PROCESS FOR PRODUCING 1,4-BENZODIOXANE DERIVATIVES DAISO CO., LTD. (JP) 1998-05-13 EP disclosed
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP disclosed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO disclosed